Evonik (EVK GY) is considering acquiring Ashland (ASH), Handelsblatt reports citing sources

Evonik (EVK GY) is considering acquiring Ashland (ASH), Handelsblatt reports citing sources.

Reported bid interest sourced to a single newspaper's unnamed sources sits in the lowest evidentiary tier of M&A news, and the established pattern in such cases is a target-side premium pop that partially retraces if no confirmation follows, while the putative acquirer's shares tend to trade soft on financing and integration arithmetic. The industrial logic here is legible: specialty chemicals has seen repeated consolidation as European producers grapple with structurally higher energy costs and seek scale in higher-margin additives and ingredients, and transatlantic combinations in this space have historically been justified on portfolio reshaping rather than synergies alone. The relevant distinction is whether this is a full takeover approach or a carve-out interest in part of the target's portfolio, since strategic buyers in chemicals have more often pursued asset-level deals to sidestep antitrust and balance-sheet strain. Follow-ons that matter are any statement or denial from either company, movement in the target's US-listed shares and credit, and whether competing bidders are named in subsequent reporting. Deal financing conditions for leveraged European industrials remain a live constraint and have killed comparable talks before.